NeoGenomics names Warren Stone as CEO, effective January 2027

NeoGenomics, Inc. (NASDAQ: NEO) announced a planned executive leadership transition, with Warren Stone, current President and Chief Operating Officer, set to become Chief Executive Officer and a member of the Board of Directors effective January 4, 2027.

Current CEO Tony Zook will remain in his role through January 3, 2027, and will then assume the position of Executive Chairman. Lynn Tetrault, who has served as Chair and Board member since 2015, will step down as Chair on January 4, 2027, continue as an independent director until the 2027 Annual Meeting of Stockholders, and will not stand for reelection at that meeting. Michael Kelly, an independent Board member since 2020, will become Lead Independent Director effective January 4, 2027.

Stone, 54, has more than three decades of experience in life sciences and diagnostics, including senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA. He joined NeoGenomics in 2022 and has held several positions, including President of Clinical Services and Chief Commercial Officer, before his current role.

"This leadership transition reflects years of deliberate succession planning by the Board and cements the continuity of our executive team and a consistent strategy for durable, profitable growth at NeoGenomics," Zook said.

Alongside the leadership announcement, NeoGenomics released preliminary, unaudited third-quarter 2026 financial results. The company expects to report total revenue of approximately $209 million for the quarter ended September 30, 2026, including year-over-year next-generation sequencing revenue growth of approximately 28%. The company said it expects to increase its full-year total revenue guidance at the midpoint, with further details to be provided on its third-quarter earnings call. Full-year adjusted EBITDA guidance was reiterated as previously provided on July 28, 2026.

The preliminary figures remain subject to completion of quarter-end closing procedures and have not been audited or reviewed by the company's independent registered public accounting firm.

You May Also Be Interested In

• SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
• Allegion acquires specialty door maker Overly Door Company
• Altura Energy extends deadline for $3M private placement to Oct. 30